Airway obstruction can be better predicted using Global Lung Function Initiative spirometry reference equations in Marfan syndrome.

Global Lung Function Initiative Marfan syndrome lung function reference values spirometry

Journal

Physiology international
ISSN: 2498-602X
Titre abrégé: Physiol Int
Pays: Hungary
ID NLM: 101696724

Informations de publication

Date de publication:
25 Mar 2021
Historique:
received: 07 05 2020
accepted: 29 08 2020
entrez: 26 3 2021
pubmed: 27 3 2021
medline: 27 3 2021
Statut: aheadofprint

Résumé

Marfan syndrome is a genetic disorder of the connective tissue, including involvement of the lungs.Pulmonary function test was performed in 32 asymptomatic adult Marfan patients using European Community for Coal and Steel (ECCS) and Global Lung Function Initiative (GLI) reference values.Using GLI equations for reference, significantly lower lung function values were noted for forced vital capacity (FVC) (87.0 ± 16.6% vs. 97.1 ± 16.9%; P < 0.01) and forced expiratory volume in the first second (FEV1) (79.6 ± 18.9% vs. 88.0 ± 19.1%; P < 0.01) predicted compared to ECCS. Obstructive ventilatory pattern was present in 25% of the cases when calculating with GLI lower limit of normal (LLN), and it was significantly more common in men as compared to women (n = 6, 50% vs. n = 2, 10%; P = 0.03).GLI is more suitable to detect early ventilatory changes including airway obstruction in young patients with special anatomic features, and should be used as a standard way of evaluation in asymptomatic Marfan population.

Identifiants

pubmed: 33769955
doi: 10.1556/2060.2021.00002
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

A M Kolonics-Farkas (AM)

1Department of Pulmonology, Semmelweis University, Budapest, Hungary.

Z Kovats (Z)

1Department of Pulmonology, Semmelweis University, Budapest, Hungary.

A Bohacs (A)

1Department of Pulmonology, Semmelweis University, Budapest, Hungary.

B Odler (B)

1Department of Pulmonology, Semmelweis University, Budapest, Hungary.
2Division of Nephrology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

K Benke (K)

3Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
4Hungarian Marfan Foundation, Budapest, Hungary.

B Agg (B)

3Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
4Hungarian Marfan Foundation, Budapest, Hungary.
5Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.

Z Szabolcs (Z)

3Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
4Hungarian Marfan Foundation, Budapest, Hungary.

V Müller (V)

1Department of Pulmonology, Semmelweis University, Budapest, Hungary.

Classifications MeSH